MedTrace Logo

Rectus Sheath Catheters Following Midline Laparotomy

NCT07099924 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-08-01

No results posted yet for this study

Summary

Rectus sheath catheters (RSC) are used for postoperative analgesia following midline laparotomies. Local anesthetics are applied to the posterior rectus sheath via the RSC. The target structures are the anterior cutaneous branches of the spinal nerves Th7-Th12. RSC can be used in particular if thoracic epidurals are contraindicated (compromised coagulation), technically unfeasible or refused by the patient.

The study investigates placebo-controlled weather RSC have a significant additional analgesic effect in a multimodal analgesic concept. Primary outcome parameters are the maximum pain score, the Quality-of-Recovery-15-Score (QoR-15GE) and the opioid consumption (morphine equivalents) in the first 72h postoperatively.

Conditions

  • Acute Abdomen
  • Ileus
  • Colorectal Carcinoma

Interventions

DRUG

Ropivacaine 0.2%

2x30ml (bilateral) ropivacaine 0.2% every 8 hours via rectus sheath catheter

DRUG

Saline 0.9%

2x30ml saline 0.9% every 8 hours via rectus sheath catheter

Sponsors & Collaborators

  • Asklepios Kliniken Hamburg GmbH

    lead OTHER

Principal Investigators

  • Ronald Seidel, Dr.med. · Asklepios Klinikum Uckermark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-31
Primary Completion
2027-08-31
Completion
2027-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07099924 on ClinicalTrials.gov